Mitochondrial dysregulation and protection in cisplatin nephrotoxicity

Archives of Toxicology

Volumn 88, Issue 6, 2014, Pages 1249-1256

  Yang, Yuan ^a   Liu, Hong ^a   Liu, Fuyou ^a   Dong, Zheng ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cisplatin; Mitochondria; Nephrotoxicity; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; BEZAFIBRATE; CASPASE 2; CISPLATIN; CYTOCHROME C; MINOCYCLINE; MITOFUSIN 1; PROTEIN P53; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT;

APOPTOSIS; AUTOPHAGY; CELL DAMAGE; CELL DEATH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA CROSS LINKING; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG EFFICACY; ENDOPLASMIC RETICULUM STRESS; KIDNEY TUBULE CELL; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL DYSREGULATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; REVIEW; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HUMAN; KIDNEY DISEASES; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DNA DAMAGE; HUMANS; KIDNEY DISEASES; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84903452610     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1239-1     Document Type: Review

References (60)

1. Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23(5):460-464
2. Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W (1997) Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome. Bone Marrow Transplant 20(10):813-819
3. Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13(3):363-373
4. Brooks C, Wei Q, Feng L, Dong G, Tao Y, Mei L, Xie Z, Dong Z (2007) Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with Mitofusins. Proc Natl Acad Sci USA 104:11649-11654
5. Brooks C, Wei Q, Cho SG, Dong Z (2009) Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 119(5):1275-1285
6. Brooks C, Cho SG, Wang CY, Yang T, Dong Z (2011) Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. Am J Physiol Cell Physiol 300(3):C447-C455
7. Chan DC (2012) Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 46:265-287
8. Cho SG, Du Q, Huang S, Dong Z (2010) Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. Am J Physiol Renal Physiol 299(1):F199-F206
9. Dong G, Luo J, Kumar V, Dong Z (2010) Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. Am J Physiol Renal Physiol 298(2):F293-F300
10. Friedman JR, Nunnari J (2014) Mitochondrial form and function. Nature 505:335-343
11. Gomez Campdera FJ, Gonzalez P, Carrillo A, Estelles MC, Rengel M (1986) Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure. Int J Pediatr Nephrol 7(3):151-152
12. Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS (1977) The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39(4):1362-1371
13. Gordon JA, Gattone VH 2nd (1986) Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol 250(6 Pt 2):F991-F998
14. Hodeify R, Megyesi J, Tarcsafalvi A, Safirstein RL, Price PM (2010) Protection of cisplatin cytotoxicity by an inactive cyclin-dependent kinase. Am J Physiol Renal Physiol 299(1):F112-F120
15. Jiang M, Dong Z (2008) Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharmacol Exp Ther 327(2):300-307
16. Jiang M, Wei Q, Wang J, Du Q, Yu J, Zhang L, Dong Z (2006) Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25(29):4056-4066
17. Jiang M, Pabla N, Murphy RF, Yang T, Yin XM, Degenhardt K, White E, Dong Z (2007) Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282(4):2636-2645
18. Jiang M, Wei Q, Dong G, Komatsu M, Su Y, Dong Z (2012) Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 82(12):1271-1283
19. Kharbangar A, Khynriam D, Prasad SB (2000) Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol 16(6):363-373
20. Kruidering M, Van de Water B, de Heer E, Mulder GJ, Nagelkerke JF (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 280(2):638-649
21. Lambat Z, Limson JL, Daya S (2002) Cimetidine: antioxidant and metal-binding properties. J Pharm Pharmacol 54(12):1681-1686
22. Lee YM, Bae SY, Won NH, Pyo HJ, Kwon YJ (2009) Alpha-lipoic acid attenuates cisplatin-induced tubulointerstitial injuries through inhibition of mitochondrial bax translocation in rats. Nephron Exp Nephrol 113(4):e104-e112
23. Liu H, Baliga R (2005) Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LC-PK1 cell apoptosis. J Am Soc Nephrol 16(7):1985-1992
24. Liu Y, Lu X, Nguyen S, Olson JL, Webb HK, Kroetz DL (2013) Epoxyeicosatrienoic acids prevent cisplatin-induced renal apoptosis through a p38 mitogen-activated protein kinase-regulated mitochondrial pathway. Mol Pharmacol 84(6):925-934
25. Livingston Man J, Dong Zheng (2014) Autophagy in acute kidney injury. Semin Nephrol 34(1):17-26
26. Lokeshwar BL (2011) Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers. Pharmacol Res 63(2):146-150
27. Maimaitiyiming H, Li Y, Cui W, Tong X, Norman H, Qi X, Wang S (2013) Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function. Am J Physiol Renal Physiol 305(6):F881-F890
28. Megyesi J, Udvarhelyi N, Safirstein RL, Price PM (1996) The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol Renal Physiol 271(6 Pt 2):1211-1216
29. Megyesi J, Safirstein RL, Price PM (1998) Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101(4):777-782
30. Mukhopadhyay P, Horváth B, Zsengellér Z, Zielonka J, Tanchian G, Holovac E, Kechrid M, Patel V, Stillman IE, Parikh SM, Joseph J, Kalyanaraman B, Pacher P (2012) Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med 52(2):497-506
31. Nagothu KK, Bhatt R, Kaushal GP, Portilla D (2005) Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 68(6):2680-2693
32. Nishikawa M, Nagatomi H, Chang BJ, Sato E, Inoue M (2001) Targeting superoxide dismutase to renal proximal tubule cells inhibits mitochondrial injury and renal dysfunction induced by cisplatin. Arch Biochem Biophys 387(1):78-84
33. Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73(9):994-1007
34. Pabla N, Huang S, Mi QS, Daniel R, Dong Z (2008) ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 283(10):6572-6583
35. Pabla N, Murphy RF, Liu K, Dong Z (2009) The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am J Physiol Renal Physiol 296(3):F505-F511
36. Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z (2011a) hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. J Biol Chem 286(12):10411-10418
37. Pabla N, Dong G, Jiang M, Huang S, Kumar MV, Messing RO, Dong Z (2011b) Inhibition of PKCaδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. J Clin Invest 121(7):2709-2722
38. Periyasamy-Thandavan S, Jiang M, Wei Q, Smith R, Yin XM, Dong Z (2008) Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 74(5):631-640
39. Price PM, Yu F, Kaldis P, Aleem E, Nowak G, Safirstein RL, Megyesi J (2006) Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 17(9):2434-2442
40. Ramesh G, Reeves WB (2002) TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110(6):835-842
41. Razzaque MS, Koji T, Kumatori A, Taguchi T (1999) Cisplatin-induced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas/Fas ligand system. Histochem Cell Biol 111(5):359-365
42. Rodrigues MA, Rodrigues JL, Martins NM, Barbosa F, Curti C, Santos NA, Santos AC (2011) Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria. Chem Biol Interact 189(1-2):45-51
43. Seth R, Yang C, Kaushal V, Shah SV, Kaushal GP (2005) p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem 280:31230-31239
44. Sugiyama S, Hayakawa M, Kato T, Hanaki Y, Shimizu K, Ozawa T (1989) Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem Biophys Res Commun 159(3):1121-1127
45. Takahashi A, Kimura T, Takabatake Y, Namba T, Kaimori J, Kitamura H, Matsui I, Niimura F, Matsusaka T, Fujita N, Yoshimori T, Isaka Y, Rakugi H (2012) Autophagy guards against cisplatin-induced acute kidney injury. Am J Pathol 180(2):517-525
46. Tanabe K, Tamura Y, Lanaspa MA, Miyazaki M, Suzuki N, Sato W, Maeshima Y, Schreiner GF, Villarreal FJ, Johnson RJ, Nakagawa T (2012a) Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy. Am J Physiol Renal Physiol 303(9):F1264-F1274
47. Tanabe K, Tamura Y, Lanaspa MA, Miyazaki M, Suzuki N, Sato W, Maeshima Y, Schreiner GF, Villarreal FJ, Johnson RJ, Nakagawa T (2012b) Epicatechin limits renal injury by mitochondrial protection in cisplatin nephropathy. Am J Physiol Renal Physiol 303(9):F1264-F1274
48. Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279(19):19948-19954
49. Wangila GW, Nagothu KK, Steward R 3rd, Bhatt R, Iyere PA, Willingham WM, Sorenson JR, Shah SV, Portilla D (2006) Prevention of cisplatin-induced kidney epithelial cell apoptosis with a Cu superoxide dismutase-mimetic [copper2II(3,5-ditertiarybutylsalic ylate)4(ethanol)4]. Toxicol In Vitro 20(8):1300-1312
50. Waseem M, Kaushik P, Parvez S (2013) Mitochondria-mediated mitigatory role of curcumin in cisplatin-induced nephrotoxicity. Cell Biochem Funct 31(8):678-684
51. Wei Q, Dong G, Franklin J, Dong Z (2007) The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 72(1):53-62
52. Wei Q, Dong G, Chen J, Ramesh G, Dong Z (2013a) Role of Bax and Bak in ischemic acute kidney injury shown by global and proximal tubule-specific knockout mouse models. Kidney Int 84(1):138-148
53. Wei Q, Dong G, Chen J, Ramesh G, Dong Z (2013b) Role of Bax and Bak in ischemic acute kidney injury shown by global and proximal tubule-specific knockout mouse models. Kidney Int 84(1):138-148
54. Yang C, Kaushal V, Shah SV, Kaushal GP (2008) Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol 294(4):F777-F787
55. Youle RJ, van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337(6098):1062-1065
56. Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331(3):851-858
57. Zauli G, Voltan R, Bosco R, Melloni E, Marmiroli S, Rigolin GM, Cuneo A, Secchiero P (2011) Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. Clin Cancer Res 17(4):762-770
58. Zhan M, Brooks C, Liu F, Sun L, Dong Z (2013) Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 83(4):568-581
59. Zhou H, Fujigaki Y, Kato A, Miyaji T, Yasuda H, Tsuji T, Yamamoto T, Yonemura K, Hishida A (2006) Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats. Am J Physiol Renal Physiol 291(1):F225-F235
60. Zsengellér ZK, Ellezian L, Brown D, Horváth B, Mukhopadhyay P, Kalyanaraman B, Parikh SM, Karumanchi SA, Stillman IE, Pacher P (2012) Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity. J Histochem Cytochem 60(7):521-529